Morningstar.com
Media Bias Ratings
Does Morningstar.com lean left or right?
Learn more about Media Bias Ratings.
Top Morningstar.com News
Latest News Stories
Joe Biden · United StatesWith about a month left before borrowers start receiving their first student-loan bill in years, roughly 4 million are enrolled in a new repayment plan the Biden administration has touted as a “game changer.”
See the Story
4 million people enroll in Biden's SAVE student loan repayment plan ahead of payment restart
77% Center coverage: 48 sources
Business · South KoreaExports fell 8.4% from a year earlier to $51.87 billion, following a revised 16.4% drop in July, according to preliminary data released by the country’s trade ministry on Friday. The median market forecast had been for an 11.5% contraction in August.
See the Story
South Korea’s exports shrink for 11th straight month
42% Center coverage: 6 sources
Joe Biden · WashingtonPresident Joe Biden on Wednesday signed an executive order that will narrowly prohibit certain U.S. investments in sensitive technology in China and require government notification of funding in other tech sectors, senior administration officials said.
See the Story
Biden signs order to ban certain tech investments in China
41% Center coverage: 130 sources
Voter · PhiladelphiaPhiladelphia Federal Reserve President Patrick Harker on Tuesday indicated that the central bank could be at the end of its current rate-hiking cycle. A voter this year on the rate-setting Federal Open Market Committee, the central bank official noted progress in the fight against inflation and confidence in the economy.
See the Story
Philadelphia Fed President Patrick Harker suggests interest rate hikes are at an end
50% Center coverage: 11 sources
Europe · BagsværdNovo Nordisk said on Tuesday a large late-stage study showed its obesity drug Wegovy had a clear medical benefit, in addition to weight loss, boosting the Danish drugmaker's hopes of moving beyond Wegovy's image as a lifestyle drug. The Danish drugmaker said the weekly injection reduced the risk of a major cardiovascular event like a stroke by 20%. The news sent shares in Europe's second-most valuable listed company up more than 10% to record highs.See the Story
Novo's weight-loss drug Wegovy cuts risk of heart disease by 20% - trial data
51% Center coverage: 35 sources
Business · SeattleAmazon said second-quarter revenue climbed 11%, and the company issued a forecast showing potential growth acceleration in the current period. The stock rose more than 5% in extended trading.See the Story
Amazon reports sales growth of 11% and issues optimistic guidance
56% Center coverage: 9 sources
